If you need more lookups,
subscriptions start at $34 USD/month.
Katie Pascoe Location
United Kingdom
Katie Pascoe Work
2026 -now Global Value and Access Director - Oncology @
2018 -2025 Global Compound Market Access Lead - Oncology @
2017 -2018 Global Value Evidence Director - mepolizumab @
2015 -2017 Value and Access Manager - Commercial @
2014 -2015 Global Value Evidence and Outcomes Manager @
2010 -2014 Senior outcomes research manager (UK) @
2006 -2010 Outcomes research manager (UK) @
2005 -2006 Outcomes researcher @
2001 -2005 PhD (Department of Surgery) and Graduate Teaching Assistant (Pharmacology) @
1997 -2000 Master of Science (Pharmacology) @
1996 -2000 Research assistant (Department of Surgery) @
Katie Pascoe Education
University of Otago
Doctor of Philosophy - PhD (Pharmacology)
2000-2005
Katie Pascoe Skills
Outcomes Research
Pharmacology
Market Access
Health technology appraisal
Health economics
Value evidence generation
Patient focused outcomes
Business Planning
Setting Strategic Direction
Life Sciences
Biotechnology
Oncology
Clinical Development
Product Launch
Strategy
Customer Service
Data Analysis
Science
Microsoft Office
PowerPoint
Health Technology Assessment Hta
Molecular Biology
Clinical Research
Health Policy
Leadership
Marketing
Healthcare
Management
Health Technology Assessment
Katie Pascoe Summary
Katie Pascoe, based in United Kingdom, is currently a Global Value and Access Director - Oncology at Gilead Sciences. Katie Pascoe brings experience from previous roles at Johnson & Johnson Innovative Medicine, GSK and The Association of the British Pharmaceutical Industry (ABPI). Katie Pascoe holds a 2000 - 2005 Doctor of Philosophy - PhD in Pharmacology @ University of Otago. With a robust skill set that includes Outcomes Research, Pharmacology, Market Access, Health technology appraisal, Health economics and more. Katie Pascoe has 1 emails on RocketReach.
Looking for a different Katie Pascoe?
Find contact details for 700 million professionals.